Latest News- Plasma Fractionation Market: Immunoglobulins is expected to lead the Product segment during 2025-2029

The Plasma Fractionation Market is being driven by Growing prevalence of plasma products treated in respiratory diseases and AATD

The Plasma Fractionation Market is expected to grow at a CAGR of 7.3% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 15685.1 million. In the aging population, the prevalence of chronic diseases, including immune disorders, neurological conditions, and autoimmune diseases, increases significantly. Plasma-derived products, such as immunoglobulins and clotting factors, play a crucial role in managing these conditions. With an anticipated rise in primary immunodeficiency disorders (PIDs) among the elderly, immunoglobulin replacement therapy derived from plasma fractionation becomes a common treatment. Moreover, plasma-derived products are essential in managing chronic diseases prevalent in older age groups, enabling patients to maintain a better quality of life and manage the complications associated with these conditions. 

Get more information on Plasma Fractionation Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Product
  • Immunoglobulins
  • Albumin
  • Coagulation factor concentrates
  • Protease inhibitors
  • Others
• Application
  • Immunology
  • Neurology
  • Hematology
  • Critical care
  • Others
• Technology
  • Chromatography
  • Filtration
  • Precipitation
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia
    • China
    • India
    • Japan
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Growing prevalence of plasma products treated in respiratory diseases and AATD
• Growing list of plasma-derived products
• Increasing in mergers and acquisitions producing plasma-based products

However, the market also witnesses some limitations, which are as follows:

• Stringent government regulations regarding safety of plasma-derived products
• Disruption of traditional methods caused by recombinant alternatives
• Development of recombinant alternatives

Benefits of Buying Global Plasma Fractionation Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Plasma Fractionation Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Plasma Fractionation Market encompasses advanced plasma fractionation techniques for protein purification and blood component separation. This involves precise process control during the fractionation process, ensuring quality control testing and regulatory guidelines compliance. Biopharmaceutical production relies on these methods for protein stability analysis, process efficiency improvement, and cost reduction strategies. Waste minimization and plasma derivative safety are also crucial considerations. Purification process validation includes immunoglobulin purification, coagulation factor concentrates, and albumin production processes. Protein aggregation control, viral safety testing, and process automation systems are essential for maintaining product quality attributes. Data analytics applications, continuous processing methods, single-use technologies, and advanced purification techniques further enhance the industry. Process analytical technology, batch processing optimization, scale-up challenges solutions, and understanding protein degradation pathways are ongoing areas of focus.

Market Research Overview

The Plasma Fractionation Market is a significant segment of the global pharmaceuticals industry, encompassing companies involved in research and development (R&D) or production of plasma protein fractionation products, such as cryoprecipitation process, albumin purification, and immunoglobulin separation. According to Technavio, the healthcare market size is determined by the consolidated revenue generated by manufacturers and providers of medical equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. The expansion of the global pharmaceuticals market will be fueled by several factors, including the increasing aging population. By 2050, approximately one-quarter of the US population and by 2030 in Europe are projected to be over 60 years old, leading to a substantial demand for plasma protein fractionation products to address the healthcare needs of this demographic.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/